Atai Life Sciences Price to Book Ratio 2020-2023 | ATAI
Historical price to book ratio values for Atai Life Sciences (ATAI) over the last 10 years. The current price to book ratio for Atai Life Sciences as of April 22, 2024 is 1.27.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Atai Life Sciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-04-22 | 1.87 | 1.27 | |
| 2023-12-31 | 1.41 | $1.47 | 0.96 |
| 2023-09-30 | 1.29 | $1.62 | 0.80 |
| 2023-06-30 | 1.72 | $1.30 | 1.32 |
| 2023-03-31 | 1.81 | $1.45 | 1.25 |
| 2022-12-31 | 2.66 | $1.60 | 1.66 |
| 2022-09-30 | 3.31 | $1.79 | 1.85 |
| 2022-06-30 | 3.64 | $1.98 | 1.84 |
| 2022-03-31 | 5.09 | $2.20 | 2.31 |
| 2021-12-31 | 7.63 | $2.40 | 3.18 |
| 2021-09-30 | 14.79 | $2.90 | 5.10 |
| 2021-06-30 | 18.50 | $3.13 | 5.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.310B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.532B | 10.00 |
| Quest Diagnostics (DGX) | United States | $14.447B | 14.94 |
| DaVita (DVA) | United States | $11.622B | 15.81 |
| Chemed (CHE) | United States | $9.137B | 28.75 |
| Encompass Health (EHC) | United States | $8.044B | 22.07 |
| Elanco Animal Health (ELAN) | United States | $6.389B | 14.53 |
| Option Care Health (OPCH) | United States | $5.286B | 20.69 |
| RadNet (RDNT) | United States | $3.263B | 95.30 |
| Amedisys (AMED) | United States | $2.981B | 21.27 |
| LifeStance Health (LFST) | United States | $2.235B | 0.00 |
| Astrana Health (ASTH) | United States | $2.075B | 26.17 |
| Addus HomeCare (ADUS) | United States | $1.517B | 23.26 |
| U.S Physical Therapy (USPH) | United States | $1.506B | 39.03 |
| Pennant (PNTG) | United States | $0.626B | 36.58 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.437B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.030B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.017B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |